Distribution of main Gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY Antimicrobial Surveillance Program (2010–2016): concomitant analysis of oritavancinin vitroactivity-Reference-Cited by-同舟云学术

Distribution of main Gram-positive pathogens causing bloodstream infections in United States and European hospitals during the SENTRY Antimicrobial Surveillance Program (2010–2016): concomitant analysis of oritavancinin vitroactivity

Published:2018-07-04 Issue:5 Volume:30 Page:280-289
ISSN:1120-009X
Container-title:Journal of Chemotherapy
language:en
Short-container-title:Journal of Chemotherapy

Author:

Mendes Rodrigo E.¹,Sader Helio S.¹,Castanheira Mariana¹,Flamm Robert K.¹

Affiliation:

1. JMI Laboratories, North Liberty, Iowa, USA

Funder

The Medicines Company

Publisher

Informa UK Limited

Subject

Infectious Diseases,Pharmacology (medical),Pharmacology,Oncology

Link

https://www.tandfonline.com/doi/pdf/10.1080/1120009X.2018.1516272

Reference36 articles.

1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

2. Sepsis in European intensive care units: Results of the SOAP study*

3. Overall burden of bloodstream infection and nosocomial bloodstream infection in North America and Europe

4. Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database*

5. Epidemiology, microbiology and outcomes of healthcare-associated and community-acquired bacteremia: A multicenter cohort study

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development of a novel integrated isothermal amplification system for detection of bacteria-spiked blood samples;AMB Express;2023-11-29

2. Oritavancin in vitro activity against Gram-positive organisms from European medical centers: a 10-year longitudinal overview from the SENTRY Antimicrobial Surveillance Program (2010–2019);Journal of Chemotherapy;2023-09-25

3. Randomised, open-label, non-inferiority clinical trial on the efficacy and safety of a 7-day vs 14-day course of antibiotic treatment for uncomplicated enterococcal bacteraemia: the INTENSE trial protocol;BMJ Open;2023-09

4. The emergence of multidrug-resistant Gram-positive bloodstream infections in India – a single center prospective cohort study;Germs;2023-09

5. Therapeutics for Vancomycin-Resistant Enterococcal Bloodstream Infections;Clinical Microbiology Reviews;2023-06-21